Global Ear Infection Treatment Market 2022-2026

Description

Technavio has been monitoring the ear infection treatment market and it is poised to grow by $ 3.67 bn during 2022-2026, progressing at a CAGR of 5.44% during the forecast period. Our report on the ear infection treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by high risk factors for ear infections, technological developments in diagnostics and surgical treatment, and increasing awareness about ear infections.

The ear infection treatment market analysis includes the type segment and geographic landscape.

Technavio's ear infection treatment market is segmented as below:

By Type

Middle ear infections
Outer ear infections
Inner ear infections

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the raising funds for research on ear infections as one of the prime reasons driving the ear infection treatment market growth during the next few years. Also, strategic alliances and the availability of off-labeled drugs will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on ear infection treatment market covers the following areas:

Ear infection treatment market sizing
Ear infection treatment market forecast
Ear infection treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ear infection treatment market vendors that include Akorn Inc., Aurobindo Pharma Ltd., Biovea, Zydus Lifesciences Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Hyland, Johnson and Johnson, Lupin Ltd., Merck and Co. Inc., Mylan NV, Novartis AG, Otonomy Inc., Perrigo Co. Plc, Sensorion, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., WraSer Pharmaceuticals, Pfizer Inc., and F. Hoffmann La Roche Ltd. Also, the ear infection treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72806

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Middle ear infections - Market size and forecast 2021-2026
Exhibit 28: Chart on Middle ear infections - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Middle ear infections - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Middle ear infections - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Middle ear infections - Year-over-year growth 2021-2026 (%)
5.4 Outer ear infections - Market size and forecast 2021-2026
Exhibit 32: Chart on Outer ear infections - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Outer ear infections - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Outer ear infections - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Outer ear infections - Year-over-year growth 2021-2026 (%)
5.5 Inner ear infections - Market size and forecast 2021-2026
Exhibit 36: Chart on Inner ear infections - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Inner ear infections - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Inner ear infections - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Inner ear infections - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Type
Exhibit 40: Market opportunity by Type ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Denmark - Market size and forecast 2021-2026
Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 India - Market size and forecast 2021-2026
Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Akorn Inc.
Exhibit 89: Akorn Inc. - Overview
Exhibit 90: Akorn Inc. - Product / Service
Exhibit 91: Akorn Inc. - Key offerings
10.4 F. Hoffmann La Roche Ltd.
Exhibit 92: F. Hoffmann La Roche Ltd. - Overview
Exhibit 93: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 94: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 95: F. Hoffmann La Roche Ltd. - Segment focus
10.5 GlaxoSmithKline Plc
Exhibit 96: GlaxoSmithKline Plc - Overview
Exhibit 97: GlaxoSmithKline Plc - Business segments
Exhibit 98: GlaxoSmithKline Plc - Key news
Exhibit 99: GlaxoSmithKline Plc - Key offerings
Exhibit 100: GlaxoSmithKline Plc - Segment focus
10.6 Johnson and Johnson
Exhibit 101: Johnson and Johnson - Overview
Exhibit 102: Johnson and Johnson - Business segments
Exhibit 103: Johnson and Johnson - Key news
Exhibit 104: Johnson and Johnson - Key offerings
Exhibit 105: Johnson and Johnson - Segment focus
10.7 Lupin Ltd.
Exhibit 106: Lupin Ltd. - Overview
Exhibit 107: Lupin Ltd. - Product / Service
Exhibit 108: Lupin Ltd. - Key news
Exhibit 109: Lupin Ltd. - Key offerings
10.8 Novartis AG
Exhibit 110: Novartis AG - Overview
Exhibit 111: Novartis AG - Business segments
Exhibit 112: Novartis AG - Key offerings
Exhibit 113: Novartis AG - Segment focus
10.9 Otonomy Inc.
Exhibit 114: Otonomy Inc. - Overview
Exhibit 115: Otonomy Inc. - Product / Service
Exhibit 116: Otonomy Inc. - Key offerings
10.10 Pfizer Inc.
Exhibit 117: Pfizer Inc. - Overview
Exhibit 118: Pfizer Inc. - Product / Service
Exhibit 119: Pfizer Inc. - Key news
Exhibit 120: Pfizer Inc. - Key offerings
10.11 Sensorion
Exhibit 121: Sensorion - Overview
Exhibit 122: Sensorion - Product / Service
Exhibit 123: Sensorion - Key offerings
10.12 WraSer Pharmaceuticals
Exhibit 124: WraSer Pharmaceuticals - Overview
Exhibit 125: WraSer Pharmaceuticals - Product / Service
Exhibit 126: WraSer Pharmaceuticals - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 127: Inclusions checklist
Exhibit 128: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 129: Currency conversion rates for US$
11.4 Research methodology
Exhibit 130: Research methodology
Exhibit 131: Validation techniques employed for market sizing
Exhibit 132: Information sources
11.5 List of abbreviations
Exhibit 133: List of abbreviations

Exhibits

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Middle ear infections - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Middle ear infections - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Middle ear infections - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Middle ear infections - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Outer ear infections - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Outer ear infections - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Outer ear infections - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Outer ear infections - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Inner ear infections - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Inner ear infections - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Inner ear infections - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Inner ear infections - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Akorn Inc. - Overview
Exhibits90: Akorn Inc. - Product / Service
Exhibits91: Akorn Inc. - Key offerings
Exhibits92: F. Hoffmann La Roche Ltd. - Overview
Exhibits93: F. Hoffmann La Roche Ltd. - Business segments
Exhibits94: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits95: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits96: GlaxoSmithKline Plc - Overview
Exhibits97: GlaxoSmithKline Plc - Business segments
Exhibits98: GlaxoSmithKline Plc - Key news
Exhibits99: GlaxoSmithKline Plc - Key offerings
Exhibits100: GlaxoSmithKline Plc - Segment focus
Exhibits101: Johnson and Johnson - Overview
Exhibits102: Johnson and Johnson - Business segments
Exhibits103: Johnson and Johnson - Key news
Exhibits104: Johnson and Johnson - Key offerings
Exhibits105: Johnson and Johnson - Segment focus
Exhibits106: Lupin Ltd. - Overview
Exhibits107: Lupin Ltd. - Product / Service
Exhibits108: Lupin Ltd. - Key news
Exhibits109: Lupin Ltd. - Key offerings
Exhibits110: Novartis AG - Overview
Exhibits111: Novartis AG - Business segments
Exhibits112: Novartis AG - Key offerings
Exhibits113: Novartis AG - Segment focus
Exhibits114: Otonomy Inc. - Overview
Exhibits115: Otonomy Inc. - Product / Service
Exhibits116: Otonomy Inc. - Key offerings
Exhibits117: Pfizer Inc. - Overview
Exhibits118: Pfizer Inc. - Product / Service
Exhibits119: Pfizer Inc. - Key news
Exhibits120: Pfizer Inc. - Key offerings
Exhibits121: Sensorion - Overview
Exhibits122: Sensorion - Product / Service
Exhibits123: Sensorion - Key offerings
Exhibits124: WraSer Pharmaceuticals - Overview
Exhibits125: WraSer Pharmaceuticals - Product / Service
Exhibits126: WraSer Pharmaceuticals - Key offerings
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations